Interventions to encourage uptake of cancer screening for people with severe mental illness.
BACKGROUND
Adults with severe mental illness (i.e. schizophrenia or other related psychotic disorders and bipolar disorder) can be at greater risk of cancer than those without severe mental illness (SMI). Early detection of cancer through screening is effective in improving patient outcomes including death. However, people with SMI are less likely than others to take up available cancer screening.


OBJECTIVE
To determine the effectiveness of interventions targeted at adults with SMI, or their carers or health professionals, and aimed at increasing the uptake of cancer screening tests for which the adults with SMI are eligible.


METHODS
We searched the Cochrane Schizophrenia Group's Trials Register (October 25, 2012; December 19, 2014; April 07, 2015; July 04, 2016).


METHODS
All randomised controlled trials (RCTs) of interventions, targeted towards adults with SMI or their carers or health professionals, to encourage uptake of cancer screening tests for which the adults with SMI were eligible.


METHODS
Two review authors independently screened titles and abstracts and assessed these against the inclusion criteria.


RESULTS
We did not find any trials that met the inclusion criteria.


CONCLUSIONS
A comprehensive search showed that currently there is no RCT evidence for any method of encouraging cancer screening uptake in people with SMI. No specific approach can therefore be recommended. High-quality, large-scale RCTs are needed urgently to help address the disparity between people with SMI and others in cancer screening uptake.
College of Nursing, Midwifery and Healthcare, University of West London, Paragon House, Boston Manor Road, Brentford, Middlesex, UK, TW8 9GA.
Elizabeth A
EA
Barley
Rohan D
RD
Borschmann
Paul
P
Walters
Andre
A
Tylee
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001865
17054144
J Clin Epidemiol. 2006 Jan;59(1):7-10
16360555
Psychiatr Serv. 2012 Aug;63(8):815-22
22660581
BMJ. 2010 Mar 23;340:c869
20332511
Cochrane Database Syst Rev. 2001;(1):CD002943
11279781
BMJ. 1996 Nov 9;313(7066):1200
8916759
J Clin Psychiatry. 1999 Apr;60(4):215-20
10221280
J Gen Intern Med. 1992 Nov-Dec;7(6):623-9
1453246
Schizophr Res. 2009 Aug;113(1):101-6
19419843
Am J Psychiatry. 1998 Nov;155(11):1490-501
9812108
BMJ. 2003 Sep 6;327(7414):557-60
12958120
Cochrane Database Syst Rev. 2000;(2):CD000389
10796539
Stat Med. 2002 Oct 15;21(19):2971-80
12325113
Arch Gen Psychiatry. 2007 Feb;64(2):242-9
17283292
Cochrane Database Syst Rev. 2000;(2):CD000172
10796502
Eur J Cancer. 2003 Aug;39(12):1718-29
12888367
Health Technol Assess. 1999;3(5):iii-92
10982317
BMJ. 1997 Sep 6;315(7108):600
9302962
Health Care Women Int. 2002 Sep-Nov;23(6-7):561-6
12418978
Acta Psychiatr Scand. 2007 Nov;116(5):317-33
17919153
Arch Womens Ment Health. 2007;10(5):189-97
17680330
Lancet Oncol. 2010 Aug;11(8):797-804
20599423
J Gen Intern Med. 2006 Oct;21(10):1097-104
16970559
Cochrane Database Syst Rev. 2000;(2):CD000409
10796542
J Natl Cancer Inst. 2003 Jun 18;95(12):868-78
12813170
Health Technol Assess. 2000;4(14):i-vii, 1-133
10984843
Int J Epidemiol. 2002 Feb;31(1):140-9
11914310
Gut. 2000 Jun;46(6):746-8
10807879
BMJ. 1997 Sep 13;315(7109):629-34
9310563
Br J Cancer. 2004 Aug 31;91(5):935-41
15280916
Med Care. 2003 Apr;41(4):560-70
12665719
J Epidemiol Community Health. 2006 Jul;60(7):600-5
16790832
Cochrane Database Syst Rev. 2001;(1):CD000362
11279688
Br J Psychiatry. 2002 Oct;181:321-5
12356659
Br J Psychiatry. 2000 Aug;177:149-55
11026955
Am J Epidemiol. 1999 May 1;149(9):876-83
10221325
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000259
22696318
Psychol Med. 1999 May;29(3):697-701
10405091